(Q37117584)

18 August 2017

The Drug Facts Box: Improving the communication of prescription drug information (English)

1 reference

18 August 2017

1

Lisa M Schwartz

1 reference

18 August 2017

2

Steven Woloshin

1 reference

PMC publication ID

3752172

18 August 2017

language of work or name

English

0 references

publication date

13 August 2013

1 reference

18 August 2017

6

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

18 August 2017

110 Suppl 3

1 reference

18 August 2017

14069-14074

1 reference

Communicating uncertainties about prescription drugs to the public: a national randomized trial

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Communicating data about the benefits and harms of treatment: a randomized trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Lost in transmission--FDA drug information that never reaches clinicians

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

The drug facts box: providing consumers with simple tabular data on drug benefit and harm

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Narrative review: the promotion of gabapentin: an analysis of internal industry documents

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

The value of benefit data in direct-to-consumer drug ads.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Direct-to-consumer prescription drug advertising and the public

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Direct to consumer advertising of prescription drugs. An idea whose time should not come

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Absolutely relative: how research results are summarized can affect treatment decisions

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

How the FDA forgot the evidence: the case of donepezil 23 mg.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Using a drug facts box to communicate drug benefits and harms: two randomized trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

The educational value of consumer-targeted prescription drug print advertising.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Direct-to-consumer prescription drug advertising builds bridges between patients and physicians

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3752172

Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1214646110

Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

21 January 2018

1 reference

12 December 2020

The framing effect of relative and absolute risk

1 reference

12 December 2020

Direct-to-consumer marketing of prescription drugs: creating consumer demand

1 reference

12 December 2020

Direct-to-Consumer Drug Advertisements on Network Television: An Exploration of Quantity, Frequency, and Placement

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.1214646110

1 reference

18 August 2017

0 references

1 reference

PMC publication ID

3752172

18 August 2017

PubMed publication ID

23942130

1 reference

PMC publication ID

3752172